A detailed history of Walleye Capital LLC transactions in Lantheus Holdings, Inc. stock. As of the latest transaction made, Walleye Capital LLC holds 20,300 shares of LNTH stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,300
Previous 25,500 20.39%
Holding current value
$1.63 Million
Previous $1.58 Million 20.11%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$51.07 - $68.26 $785,609 - $1.05 Million
15,383 Added 714.49%
17,536 $1.09 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $119,706 - $167,697
2,153 New
2,153 $133,000
Q2 2023

Aug 14, 2023

BUY
$82.41 - $99.65 $1.5 Million - $1.82 Million
18,260 Added 442.56%
22,386 $1.88 Million
Q1 2023

May 15, 2023

SELL
$47.76 - $82.86 $1.14 Million - $1.99 Million
-23,966 Reduced 85.31%
4,126 $340,000
Q4 2022

Feb 14, 2023

BUY
$48.76 - $77.67 $1.37 Million - $2.18 Million
28,092 New
28,092 $1.43 Million
Q2 2022

Aug 08, 2022

SELL
$55.54 - $72.65 $591,223 - $773,359
-10,645 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$24.28 - $56.64 $220,049 - $513,328
-9,063 Reduced 45.99%
10,645 $589,000
Q4 2021

Mar 03, 2022

BUY
$22.54 - $30.44 $263,605 - $355,995
11,695 Added 145.95%
19,708 $569,000
Q3 2021

Nov 15, 2021

SELL
$24.23 - $28.59 $210,704 - $248,618
-8,696 Reduced 52.04%
8,013 $206,000
Q2 2021

Aug 16, 2021

BUY
$19.51 - $27.64 $325,992 - $461,836
16,709 New
16,709 $462,000
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $173,193 - $240,215
-16,111 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$11.98 - $16.34 $240,414 - $327,911
-20,068 Reduced 55.47%
16,111 $204,000
Q2 2020

Aug 14, 2020

BUY
$10.34 - $15.51 $258,696 - $388,044
25,019 Added 224.18%
36,179 $517,000
Q1 2020

May 15, 2020

BUY
$9.11 - $20.05 $101,667 - $223,758
11,160 New
11,160 $142,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.52B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.